Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Mammary epithelial-specific expression of the integrin linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice

Abstract

The integrin linked kinase (ILK) is a cytoplasmic effector of integrin receptors, involved in the regulation of integrin binding properties as well as the activation of cell survival and proliferative pathways, including those involving MAP kinase, PKB/Akt and GSK-3β. Overexpression of ILK in cultured intestinal and mammary epithelial cells has been previously shown to induce changes characteristic of oncogenic transformation, including anchorage-independent growth, invasiveness, suppression of anoikis and tumorigenicity in nude mice. In order to determine if ILK overexpression can result in the formation of mammary tumors in vivo, we generated transgenic mice expressing ILK in the mammary epithelium, under the transcriptional control of the mouse mammary tumor virus (MMTV) long terminal repeat (LTR). By the age of 6 months, female MMTV/ILK mice developed a hyperplastic mammary phenotype, which was accompanied by the constitutive phosphorylation of PKB/Akt, GSK-3β and MAP kinase. Focal mammary tumors subsequently appeared in 34% of the animals at an average age of 18 months. Given the focal nature and long latency of the tumors, however, additional genetic events are likely required for tumor induction in the MMTV/ILK mice. These results provide the first direct demonstration of a potential oncogenic role for ILK, which is upregulated in human tumors and tumor cell lines.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Attwell S, Roskelley C, Dedhar S . 2000 Oncogene 19: 3811–3815

  • Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ . 1979 Biochemistry 18: 5294–5299

  • Chung DH, Lee JI, Kook MC, Kim JR, Kim SH, Choi EY, Park SH, Song HG . 1998 Vir. Arch. 433: 113–117

  • Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA . 1995 Nature 378: 785–789

  • Dedhar S . 2000 Curr. Opin. Cell Biol. 12: 250–256

  • Delcommenne M, Tan C, Gray V, Rue L, Woodgett J, Dedhar S . 1998 Proc. Natl. Acad. Sci. USA 95: 11211–11216

  • Deng JT, Van Lierop JE, Sutherland C, Walsh MP . 2001 J. Biol. Chem. 276: 16365–16373

  • Giancotti FG, Ruoslahti E . 1999 Science 285: 1028–1032

  • Graff JF, Deddens JA, Konicek BW, Colligan BM, Hurst BM, Carter HW, Carter JH . 2001 Clin. Cancer Res. 7: 1987–1991

  • Hannigan GE, Leung-Hagesteijn C, Fitz-Gibbon L, Coppolino MG, Radeva G, Filmus J, Bell JC, Dedhar S . 1996 Nature 379: 91–96

  • Huang Y, Li J, Zhang Y, Wu C . 2000 J. Cell Biol. 150: 861–871

  • Hutchinson J, Jin J, Cardiff RD, Woodgett JR, Muller WJ . 2001 Mol. Cell. Biol. 21: 2203–2212

  • Janji B, Melchior C, Gouon V, Vallar L, Kieffer N . 1999 Int. J. Cancer 83: 255–262

  • Janji B, Melchior C, Gouon V, Vallar L, Kieffer N . 2000 Oncogene 19: 3069–3077

  • Landesman-Bollag E, Romieu-Mourez R, Song DH, Sonenshein GE, Cardiff RD, Seldin DC . 2001 Oncogene 20: 3247–3257

  • Muller WJ, Sinn E, Pattengale PK, Wallace R, Leder P . 1988 Cell 54: 105–115

  • Novak A, Hsu S-C, Leung-Hagesteijn C, Raddeva G, Papkoff J, Montesano R, Roskelley C, Grosschedl R, Dedhar S . 1998 Proc. Natl. Acad. Sci. USA 95: 4374–4379

  • Persad S, Attwell S, Gray V, Delcommenne M, Troussard A, Sanghera J, Dedhar S . 2000 Proc. Natl. Acad. Sci. USA 97: 3207–3212

  • Persad S, Attwell S, Gray V, Mawji N, Deng JT, Leung D, Yan J, Sanghera J, Walsh MP, Dedhar S . 2001a J. Biol. Chem. 276: 27462–27469

  • Persad S, Troussard A, McPhee TR, Mulholland D, Dedhar S . 2001b J. Cell Biol. 153: 1161–1174

  • Radeva G, Petrocelli T, Behrend E, Leung-Hagesteijn C, Filmus J, Slingerland J, Dedhar S . 1997 J. Biol. Chem. 272: 13937–13944

  • Schmeichel KL, Weaver VM, Bissell MJ . 1998 J. Mammary Gland Biol. Neoplasia 3: 201–213

  • Seger D, Seger R, Shaltiel S . 2001 J. Biol. Chem. 276: 16998–17006

  • Shaw LM . 1999 J. Mammary Gland Biol. Neoplasia 4: 367–376

  • Sinn E, Muller W, Pattengale P, Tepler I, Wallace R, Leder P . 1987 Cell 49: 465–475

  • Somasiri A, Howarth A, Goswami D, Dedhar S, Roskelley CD . 2001 J. Cell Sci. 114: 1125–1136

  • Song DH, Sussman J, Seldin DC . 2000 J. Biol. Chem. 275: 23790–23797

  • Sternlicht MD, Bissell MJ, Werb Z . 2000 Oncogene 19: 1102–1113

  • Streuli CH, Edwards GM . 1998 J. Mammary Gland Biol. Neoplasia 3: 151–163

  • Troussard AA, Tan C, Yoganathan N, Dedhar S . 1999 Mol. Cell. Biol. 19: 7420–7427

  • Troussard AA, Costello P, Yoganathan TN, Kumagai S, Roskelley CD, Dedhar S . 2000 Oncogene 19: 5444–5452

  • Tu Y, Li F, Goicoechea S, Wu C . 1999 Mol. Cell. Biol. 19: 2425–2434

  • Webster MA, Hutchinson JN, Rauh MJ, Muthuswamy SK, Anton M, Tortorice CG, Cardiff RD, Graham FL, Hassell JA, Muller WJ . 1998 Mol. Cell. Biol. 18: 2344–2359

  • Wu C, Keightley SY, Leung-Hagesteijn C, Radeva G, Coppolino M, Boicoechea S, McDonald JA, Dedhar S . 1998 J. Biol. Chem. 273: 528–536

  • Yoganathan TN, Costello P, Chen X, Jabali M, Yan J, Leung D, Zhang Z, Yee A, Dedhar S, Sanghera J . 2000 Biochem. Pharmacol. 60: 1115–1119

  • Zervas CG, Gregory SL, Brown NH . 2001 J. Cell Biol. 152: 1007–1018

  • Zutter MM, Sun H, Santoro SA . 1998 J. Mammary Gland Biol. Neoplasia 3: 191–200

Download references

Acknowledgements

The authors would like to thank Judy E Walls (UC Davis School of Medicine) for excellent technical work on the immunohistochemistry, and Monica Graham (McMaster University) for genotyping the ILK strains. This work was supported by the US Department of Defense Breast Cancer Research Initiative DAMD 17-99-1-9284 (D White) and DAMD 17-99-1-9286 (WJ Muller), by grants from the National Cancer Institute of Canada (S Dedhar), and by grant 5JB-0014 from the State of California Breast Cancer Research Program (RD Cardiff).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to William J Muller.

Rights and permissions

Reprints and permissions

About this article

Cite this article

White, D., Cardiff, R., Dedhar, S. et al. Mammary epithelial-specific expression of the integrin linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice. Oncogene 20, 7064–7072 (2001). https://doi.org/10.1038/sj.onc.1204910

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204910

Keywords

This article is cited by

Search

Quick links